Oklo (OKLO) Stock: Rebounds After Reactor Startup Authorization Advances Nuclear Expansion
TLDR
-
Oklo stock rose 1.21% pre-market after DOE startup authorization news.
-
DOE cleared Groves reactor for fuel loading, testing, and operations.
-
Groves supports domestic isotope production for healthcare and research.
-
Privately funded reactor establishes a repeatable commercial deployment model.
-
Groves experience strengthens Oklo’s future advanced nuclear project pipeline.
Oklo Inc. (OKLO) shares closed at $44.00, down 1.12%, before rising 1.21% to $44.54 in pre-market trading. The recovery followed the company’s announcement that it received startup authorization for its Groves Isotope Test Reactor. The approval allows fuel loading, startup testing, and reactor operations under the U.S. Department of Energy Reactor Pilot Program.
DOE Approval Clears Path for Reactor Operations
The U.S. Department of Energy granted startup authorization after completing its review under the Reactor Pilot Program. As a result, Oklo can begin fuel loading, startup testing, and reactor operations at the Groves Isotope Test Reactor. The authorization completes the federal approval process for the facility.
… Continue reading the full article at the original source below.
